GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CogState CGS.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

3.36

+2.13%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About CogState

Its shares trade on ASX under the ticker CGS.AX. It has been listed since 13 February 2004. In the fiscal year to 30 June 2025, it reported revenue of $53.1m and net income of $10.1m. At that date it held total assets of $64.8m and shareholders' equity of $47.9m.

Cogstate Ltd. is a global cognitive science company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-02-13. The firm's segments include cognitive testing in Clinical Trials; the precision recruitment market, the healthcare market, the sport market and administration. In the clinical trials market, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the precision recruitment market, the technology is used as an online screening tool as part of the process of recruiting subjects in clinical trials. In the healthcare market, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. In the sport market, the technology and associated services are used to provide concussion management tools in sport.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Technology
Listed since
13 Feb 2004
Employees
61

Leadership

Pay as last reported

  • Mr. Martyn MyerNon-Executive Chairman of the Board$94,621
  • Mr. Brad O'ConnorChief Executive Officer, Managing Director, Executive Director, since 2004$1.1m
  • Mr. Darren WatsonChief Financial Officer$469,060
  • Ms. Rachel ColiteExecutive Vice President - Clinical Trials$41,665
  • Mr. Chris EdgarChief Scientific Officer$421,929
  • Ms. Kristi GeddesGeneral Counsel, Joint Company Secretary
  • Dr. Kaycee SinkChief Medical Officer
  • Mr. David FranksCompany Secretary
  • Dr. Richard MohsIndependent Non-Executive Director$62,755
  • Ms. Ingrid PlayerIndependent Non-Executive Director$70,966
  • Mr. Richard van Den BroekIndependent Non-Executive Director$56,149
  • Ms. Kim WennIndependent Non-Executive Director$64,207

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.